文献速递心脑血管急症重症综合管理与镇静镇痛

危重型COVID-19患者中的缺血性与出血性卒中:一项国际多中心COVID-19重症监护联盟研究

Ischemic and Hemorrhagic Stroke Among Critically Ill Patients With Coronavirus Disease 2019: An International Multicenter Coronavirus Disease 2019 Critical Care Consortium Study.
PubMed 文献 · Crit Care Med · 2021-01-01
一句话结论在ICU的COVID-19患者中卒中不常见(2.2%),出血性卒中增加死亡风险(HR=2.74),缺血性卒中不增加;ECMO使用与两类卒中均强相关。

该研究为对前瞻性收集数据库的回顾性分析,纳入全球370余家ICU的2699例成人COVID-19患者,评估急性卒中的患病率与结局。结果显示59例(2.2%)发生急性卒中:缺血性0.7%、出血性1.0%、未明确0.5%。系统性抗凝使用与任何类型卒中无关;糖尿病、高血压和吸烟在缺血性卒中患者中更常见。ECMO支持在出血性(56%)和缺血性(16%)卒中患者中比无卒中者(10%)更常见,ECMO患者出血性和缺血性卒中的90天累积概率相对风险分别为10.5和1.7。出血性卒中增加死亡风险(HR=2.74),缺血性卒中则不然。

要点

  • ICU的COVID-19患者中急性卒中总体患病率为2.2%,其中缺血性0.7%、出血性1.0%、未明确0.5%。
  • 出血性卒中增加死亡风险(HR=2.74),缺血性卒中未显示增加死亡风险。
  • ECMO支持患者出血性卒中相对风险为10.5、缺血性卒中相对风险为1.7(对比非ECMO患者)。
  • 系统性抗凝使用与任何类型卒中均无关联。
  • 糖尿病、高血压和吸烟在缺血性卒中患者中比无卒中及出血性卒中患者更常见。

适用人群与场景

  • 年龄大于18岁、因急性COVID-19感染入住ICU的患者,来自全球370余家国际中心。
  • 排除标准原文未提及。

诊断标准与关键阈值

  • 急性卒中诊断依据原文未提及具体标准或阈值。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型:对前瞻性收集数据库的回顾性分析;样本量2699例,来自370余家国际中心;人群为ICU成人COVID-19患者。
  • 主要结局:59例(2.2%)发生急性卒中,其中缺血性0.7%、出血性1.0%、未明确0.5%。
  • 系统性抗凝使用与任何类型卒中无关联。
  • 糖尿病、高血压和吸烟在缺血性卒中患者中比无卒中及出血性卒中患者更常见。
  • ECMO支持在出血性卒中(56%)和缺血性卒中(16%)患者中比无卒中患者(10%)更常见;ECMO患者出血性卒中相对风险=10.5,缺血性卒中相对风险=1.7(对比非ECMO患者)。
  • 出血性卒中增加死亡风险(HR=2.74),缺血性卒中未增加死亡风险。

证据类型、等级与局限

  • 证据类型:回顾性分析前瞻性收集数据库(观察性研究)。
  • 证据等级或推荐强度原文未提及。
  • 局限:回顾性设计;原文未提及其他局限。

对床旁实践的改变

  • 原文未提及

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

OBJECTIVES: Stroke has been reported in observational series as a frequent complication of coronavirus disease 2019, but more information is needed regarding stroke prevalence and outcomes. We explored the prevalence and outcomes of acute stroke in an international cohort of patients with coronavirus disease 2019 who required ICU admission.

DESIGN: Retrospective analysis of prospectively collected database.

SETTING: A registry of coronavirus disease 2019 patients admitted to ICUs at over 370 international sites was reviewed for patients diagnosed with acute stroke during their stay.

PATIENTS: Patients older than 18 years old with acute coronavirus disease 2019 infection in ICU.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: Of 2,699 patients identified (median age 59 yr; male 65%), 59 (2.2%) experienced acute stroke: 0.7% ischemic, 1.0% hemorrhagic, and 0.5% unspecified type. Systemic anticoagulant use was not associated with any stroke type. The frequency of diabetes, hypertension, and smoking was higher in patients with ischemic stroke than in stroke-free and hemorrhagic stroke patients. Extracorporeal membrane oxygenation support was more common among patients with hemorrhagic (56%) and ischemic stroke (16%) than in those without stroke (10%). Extracorporeal membrane oxygenation patients had higher cumulative 90-day probabilities of hemorrhagic (relative risk = 10.5) and ischemic stroke (relative risk = 1.7) versus nonextracorporeal membrane oxygenation patients. Hemorrhagic stroke increased the hazard of death (hazard ratio = 2.74), but ischemic stroke did not-similar to the effects of these stroke types seen in noncoronavirus disease 2019 ICU patients.

CONCLUSIONS: In an international registry of ICU patients with coronavirus disease 2019, stroke was infrequent. Hemorrhagic stroke, but not ischemic stroke, was associated with increased mortality. Further, both hemorrhagic stroke and ischemic stroke were associated with traditional vascular risk factors. Extracorporeal membrane oxygenation use was strongly associated with both stroke and death.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Cho SM, Premraj L, Fanning J, et al. Ischemic and Hemorrhagic Stroke Among Critically Ill Patients With Coronavirus Disease 2019: An International Multicenter Coronavirus Disease 2019 Critical Care Consortium Study. Crit Care Med. 2021. PMID: 34269719. doi:10.1097/CCM.0000000000005209

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。